The neurobiology of the switch process in bipolar disorder: a review
- PMID: 20492846
- PMCID: PMC3000635
- DOI: 10.4088/JCP.09r05259gre
The neurobiology of the switch process in bipolar disorder: a review
Abstract
Objective: The singular phenomenon of switching from depression to its opposite state of mania or hypomania, and vice versa, distinguishes bipolar disorder from all other psychiatric disorders. Despite the fact that it is a core aspect of the clinical presentation of bipolar disorder, the neurobiology of the switch process is still poorly understood. In this review, we summarize the clinical evidence regarding somatic interventions associated with switching, with a particular focus on the biologic underpinnings presumably involved in the switch process.
Data sources: Literature for this review was obtained through a search of the MEDLINE database (1966-2008) using the following keywords and phrases: switch, bipolar disorder, bipolar depression, antidepressant, SSRIs, tricyclic antidepressants, norepinephrine, serotonin, treatment emergent affective switch, mania, hypomania, HPA-axis, glucocorticoids, amphetamine, dopamine, and sleep deprivation.
Study selection: All English-language, peer-reviewed, published literature, including randomized controlled studies, naturalistic and open-label studies, and case reports, were eligible for inclusion.
Data synthesis: Converging evidence suggests that certain pharmacologic and nonpharmacologic interventions with very different mechanisms of action, such as sleep deprivation, exogenous corticosteroids, and dopaminergic agonists, can trigger mood episode switches in patients with bipolar disorder. The switch-inducing potential of antidepressants is unclear, although tricyclic antidepressants, which confer higher risk of switching than other classes of antidepressants, are a possible exception. Several neurobiological factors appear to be associated with both spontaneous and treatment-emergent mood episode switches; these include abnormalities in catecholamine levels, up-regulation of neurotrophic and neuroplastic factors, hypothalamic-pituitary-adrenal axis hyperactivity, and circadian rhythms.
Conclusions: There is a clear need to improve our understanding of the neurobiology of the switch process; research in this field would benefit from the systematic and integrated assessment of variables associated with switching.
© Copyright 2010 Physicians Postgraduate Press, Inc.
Figures
Comment in
-
Anticholinergic mechanisms: a forgotten cause of the switch process in bipolar disorder.J Clin Psychiatry. 2010 Dec;71(12):1698-9; author reply 1699-700. doi: 10.4088/JCP.10lr06389yel. J Clin Psychiatry. 2010. PMID: 21190643 No abstract available.
Similar articles
-
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.Am J Psychiatry. 2006 Feb;163(2):232-9. doi: 10.1176/appi.ajp.163.2.232. Am J Psychiatry. 2006. PMID: 16449476 Clinical Trial.
-
Bipolar depression and antidepressant-induced mania: a naturalistic study.J Clin Psychiatry. 1998 Jul;59(7):374-9. doi: 10.4088/jcp.v59n0706. J Clin Psychiatry. 1998. PMID: 9714266 Clinical Trial.
-
Antidepressant-induced mania in bipolar patients: identification of risk factors.J Clin Psychiatry. 2001 Apr;62(4):249-55. doi: 10.4088/jcp.v62n0406. J Clin Psychiatry. 2001. PMID: 11379838 Clinical Trial.
-
Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.J Clin Psychiatry. 2006 Dec;67(12):1836-55. doi: 10.4088/jcp.v67n1203. J Clin Psychiatry. 2006. PMID: 17194261 Review.
-
The use of antidepressants in bipolar disorder.J Clin Psychiatry. 2008 Aug;69(8):1307-18. doi: 10.4088/jcp.v69n0816. J Clin Psychiatry. 2008. PMID: 18681751 Review.
Cited by
-
The Emergence of Mania After Initiating Escitalopram for Anxiety Disorder.Cureus. 2024 Jun 29;16(6):e63441. doi: 10.7759/cureus.63441. eCollection 2024 Jun. Cureus. 2024. PMID: 39077268 Free PMC article.
-
A bipolar disorder-associated missense variant alters adenylyl cyclase 2 activity and promotes mania-like behavior.Mol Psychiatry. 2024 Jul 13. doi: 10.1038/s41380-024-02663-w. Online ahead of print. Mol Psychiatry. 2024. PMID: 39003412
-
Lysophosphatidic Acid (LPA) and Its Receptors in Mood Regulation: A Systematic Review of the Molecular Mechanisms and Therapeutic Potential.Int J Mol Sci. 2024 Jul 6;25(13):7440. doi: 10.3390/ijms25137440. Int J Mol Sci. 2024. PMID: 39000547 Free PMC article. Review.
-
Compulsive Biting and Chewing with Mixed Amphetamine Salts: A Case Report.Innov Clin Neurosci. 2024 Jun 1;21(4-6):11-13. eCollection 2024 Apr-Jun. Innov Clin Neurosci. 2024. PMID: 38938532 Free PMC article.
-
Environmental pollution and extreme weather conditions: insights into the effect on mental health.Front Psychiatry. 2024 May 28;15:1389051. doi: 10.3389/fpsyt.2024.1389051. eCollection 2024. Front Psychiatry. 2024. PMID: 38863619 Free PMC article. Review.
References
-
- Falret J. Mémoire sur la folie circulaire, forme de maladie mentale caractérisée par la reproduction sucessive et réguliäre de l'état maniqaue, de l'état mélancolique, et d'un intervalle lucide plus or moins prolongé. Bull Acad Natl Med. 1854;19:382–415.
-
- Sedler MJ. Falret's discovery: the origin of the concept of bipolar affective illness. Translated by M. J. Sedler and Eric C. Dessain. Am J Psychiatry. 1983;140(9):1127–1133. - PubMed
-
- Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry. 2000;48(6):445–457. - PubMed
-
- Angst J. Switch from depression to mania, or from mania to depression: role of psychotropic drugs. Psychopharmacol Bull. 1987;23(1):66–67. - PubMed
-
- Licht RW, Gijsman H, Nolen WA, Angst J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand. 2008;118(5):337–346. - PubMed